Showing 20 of 25 recruiting trials for “pituitary-carcinoma”
DDAVP for Pituitary Adenoma
👨⚕️ Prashant Chittiboina, M.D., National Institute of Neurological Disorders and Stroke (NINDS)📍 1 site📅 Started Mar 2026View details ↗
Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas
RecruitingNCT07268183 ↗
How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors
Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease
Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
👨⚕️ Cihan Atila, Dr., University Hospital Basel, Dept. of Endocrinology, Metabolism & Diabetes📍 1 site📅 Started Sep 2025View details ↗
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
👨⚕️ Anna S Wenning, MD, PhD, Department of Visceral Surgery and Medicine Inselspital, Bern University Hospital📍 7 sites📅 Started May 2025View details ↗
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
Molecular Pituitary Imaging Using 18F-FET PET
👨⚕️ Mark Gurnell, MD, PhD, Cambridge University Hospitals NHS Foundation Trust📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT07335315 ↗
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
Physical Attendance Versus Telephone or Video Follow-up in Patients With Non-functioning Pituitary Tumors.
Individualized Physical Activity or Patients With Non Functioning Pituitary Adenoma
RecruitingNCT07463625 ↗
Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
👨⚕️ Gabriel A Brooks, M.D., Dartmouth-Hitchcock Medical Center📍 1 site📅 Started Jul 2023View details ↗
Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma
👨⚕️ Liu Guohua, Affiliated Hospital of Guangdong Medical University📍 1 site📅 Started Jul 2023View details ↗
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
👨⚕️ Moh'd Abu Hilal, MD, PhD, Fondazione Poliambulanza Instituto Ospedaliero📍 1 site📅 Started Jul 2023View details ↗
Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
👨⚕️ Nadine Abi-Jaoudeh, MD, Chao Family Comprehensive Cancer Center📍 1 site📅 Started Sep 2022View details ↗
Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →